Long-term effects of discontinuing renin-angiotensin system inhibitors in COVID-19.

Theurl, Fabian; Sappler, Nikolay; Rizas, Konstantinos D; Massberg, Steffen; Bauer, Axel; Schreinlechner, Michael

Theurl, Fabian; Sappler, Nikolay; Rizas, Konstantinos D; Massberg, Steffen; Bauer, Axel; Schreinlechner, Michael.

Theurl F; Department of Internal Medicine III, Cardiology & Angiology, Medical University of Innsbruck, Innsbruck, Austria.
Sappler N; Department of Internal Medicine III, Cardiology & Angiology, Medical University of Innsbruck, Innsbruck, Austria.
Rizas KD; Medizinische Klinik und Poliklinik I, LMU University Hospital Munich, Munich, Germany.
Massberg S; German Center for Cardiovascular Research (DZHK) Partner Site: Munich Heart Alliance, Munich, Germany.
Bauer A; Medizinische Klinik und Poliklinik I, LMU University Hospital Munich, Munich, Germany.
Schreinlechner M; German Center for Cardiovascular Research (DZHK) Partner Site: Munich Heart Alliance, Munich, Germany.

Respirology ; 27(9): 788-790, 2022 09.

Article in English | MEDLINE | ID: covidwho-1879104

Subject(s)

COVID-19 Drug Treatment; Hypertension; Angiotensin Receptor Antagonists/pharmacology; Angiotensin Receptor Antagonists/therapeutic use; Antihypertensive Agents/pharmacology; Antihypertensive Agents/therapeutic use; Humans; Hypertension/drug therapy; Renin-Angiotensin System; SARS-CoV-2

Keywords

COVID-19; SARS-CoV-2; antihypertensive drugs; hypertension; renin-angiotensin-system inhibitors (RASi)

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hypertension Type of study: Experimental Studies Topics: Long Covid Limits: Humans Language: English Journal: Respirology Year: 2022 Document Type: Article Affiliation country: Resp.14306

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google